Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease. [electronic resource]
Producer: 20141014Description: 447-58 p. digitalISSN:- 1365-2036
- Adalimumab
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Certolizumab Pegol
- Colitis, Ulcerative -- drug therapy
- Crohn Disease -- drug therapy
- Humans
- Immunoglobulin Fab Fragments -- adverse effects
- Infliximab
- Neoplasms -- chemically induced
- Polyethylene Glycols -- adverse effects
- Randomized Controlled Trials as Topic
- Risk
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.